FindTrial
Sign In

EFFICACY OF AKSHITARPANA AND PANA OF MAHATRIPHALADI GHRITA IN THE MANAGEMENT OF TIMIRA (MYOPIA)

EFFICACY OF AKSHITARPANA AND PANA OF MAHATRIPHALADI GHRITA IN THE MANAGEMENT OF TIMIRA (MYOPIA) AN OPEN LABELLED RANDOMIZED COMPARATIVE CLINICAL TRIAL - myopia

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023501
Enrollment
30
Registered
2020-02-21
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H531- Subjective visual disturbances

Interventions

Intervention1: Tarpana and orally(Pana) of Mahatriphaladi ghrita: Mahatriphaladi Ghrita for tarpana and orally(Pana) in group A and only Tarpana in group B Tarpana of mahatriphaladi ghrita Dose:30gra

Sponsors

Institutye for Post Graduate Teaching and Research in Ayurveda Gujarat Ayurved University Jamnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patient within the age group of 10-25 years with normal fundus will be included in the study Patients having signs and symptoms of Timira(Myopia) describe as per Ayurveda and Modern science Myopia upto-6D will be included in the study

Exclusion criteria

Exclusion criteria: Patient below age of 10 years and above 25 years Patient having any other known ocular pathology eg cataract glaucoma orneal opacity and other retinal diseases Patient having myopia more than 6D Patient having myopic degenerative changes Patient having Juvenile Diabetes Mellitus

Design outcomes

Primary

MeasureTime frame
Relief in signs and symptoms of TimirTimepoint: after 4 weeks of the trial—

Secondary

MeasureTime frame
Improvement in quality of life and social well being of patientsTimepoint: within 1 year from the trial—

Countries

India

Contacts

Public ContactDr D B Vaghela

Institute for Post Graduate Teaching and Research In Ayurveda Gujrat Ayurved Univercity JamnagaS

drvaghela@rediffmail.com9825407899

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026